Name: China SXT Pharmaceuticals, Inc. (SXTC) Balance Sheet
Creator: FinSpry

China SXT Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for China SXT Pharmaceuticals, Inc. (SXTC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Current Assets
Cash and Cash Equivalents	18.10	12.07	17.37	15.52	13.33
Short-Term Investments	0.14	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	18.10	12.07	17.37	15.52	13.33
Accounts Receivable	1.90	1.35	1.58	5.53	6.66
Inventory	0.83	0.81	0.58	1.07	1.38
Other Current Assets	0.47	0.00	0.00	0.29	0.00
Total Current Assets	21.30	14.23	19.52	22.45	23.23
Non-Current Assets
Property, Plant & Equipment (Net)	0.36	0.56	1.27	1.59	1.79
Intangible Assets	0.01	0.02	0.03	0.04	0.05
Other Non-Current Assets	0.00	8.31	8.74	9.46	9.16
Total Non-Current Assets	0.37	8.89	10.03	11.09	0.00
Total Assets	21.66	23.13	29.55	33.55	34.55
Current Liabilities
Accounts Payable	1.16	1.28	1.38	1.48	1.46
Short-Term Debt	0.77	0.02	0.01	0.01	0.04
Current Portion of Long-Term Debt	0.01	0.02	0.01	0.01	0.04
Accrued Liabilities	1.78	1.59	1.74	2.01	1.51
Deferred Revenue	0.06	0.19	0.17	0.08	0.00
Other Current Liabilities	2.99	1.39	1.52	1.72	2.26
Total Current Liabilities	6.01	8.90	14.50	17.12	18.58
Non-Current Liabilities
Long-Term Debt	0.21	0.12	0.12	0.00	0.01
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.21	0.29	0.37	0.00	0.00
Total Liabilities	6.22	9.20	14.86	17.12	18.59
Stockholders' Equity
Common Stock	44.53	39.67	0.91	0.16	0.06
Retained Earnings	-28.02	-24.71	-21.61	-15.69	-9.95
Accumulated Other Comprehensive Income	-1.08	-1.03	-0.20	0.96	0.53
Additional Paid-in Capital	0.00	35.32	35.59	30.99	0.00
Shares Outstanding	0.09	0.00	0.00	0.00	0.00
Total Stockholders' Equity	15.44	13.93	14.69	16.42	15.96
Total Liabilities & Equity	21.66	23.13	29.55	33.55	0.00